3-[4-(aminomethyl)phenyl]-1,2,4-oxadiazol-5(4H)-one hydrochloride | 1097196-63-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3-[4-(aminomethyl)phenyl]-1,2,4-oxadiazol-5(4H)-one hydrochloride
• 英文别名: 3-[4-(aminomethyl)phenyl]-1,2,4-oxadiazol-5-one hydrochloride；3-[4-(aminomethyl)phenyl]-4H-1,2,4-oxadiazol-5-one;hydrochloride
• CAS: 1097196-63-8
• 化学式: C₉H₉N₃O₂*ClH
• 分子量: 227.65
• InChiKey: JIGHVXSVVZISNE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.91
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  76.7
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-[4-(aminomethyl)phenyl]-1,2,4-oxadiazol-5(4H)-one hydrochloride 、 (S)-2-tert-butyloxycarbonylamino-4-(1-(4-nitrobenzyloxy)carbonylpiperidin-4-yl)butanoic acid 、 三氟乙酸 在 N-甲基吗啉 、 氯甲酸异丁酯 作用下， 以 N,N-二甲基甲酰胺 、 二氯甲烷 为溶剂， 反应 1.17h， 以74%的产率得到(R)-2-amino-4-(1-(4-nitrobenzyloxycarbonyl)piperidin-4-yl)butanoic acid (5-oxo-1,2,4-oxadiazolin-3-ylbenzyl)amide trifluoroacetate
  参考文献：
  名称：

  [EN] TRYPSIN-LIKE SERINE PROTEASE INHIBITORS, AND THEIR PREPARATION AND USE
  [FR] INHIBITEURS DE SÉRINE PROTÉASE DE TYPE TRYPSINE, ET LEUR PRÉPARATION ET UTILISATION

  摘要：

  公开号：

  WO2011094496A3
• 作为产物：
  描述：

  tert-butyl 4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)benzylcarbamate 在 盐酸 作用下， 以 1,4-二氧六环 为溶剂， 反应 1.0h， 以100%的产率得到3-[4-(aminomethyl)phenyl]-1,2,4-oxadiazol-5(4H)-one hydrochloride
  参考文献：
  名称：

  4-알키닐이미다졸 유도체 및 그것을 유효 성분으로서 함유하는 의약

  摘要：

  具有优异的EP4受体拮抗作用，EP4受体相关的治疗疾病的药物，例如用于治疗炎症性疾病或伴有多种疼痛的疾病的抗炎和/或镇痛药物，同时也激活Th1细胞和/或Th17细胞，导致组织破坏引起炎症导致的免疫性疾病的治疗药物，提供4-烷基咪唑衍生物或其药理学上可接受的盐，如下所示的通用式(I)。【化学式1】

  公开号：

  KR20160018745A

文献信息

• 4-알키닐이미다졸 유도체 및 그것을 유효 성분으로서 함유하는 의약
  申请人：KAKEN PHARMACEUTICAL CO., LTD. 가껭세이야꾸가부시기가이샤(519952409889)

  公开号：KR20160018745A

  公开（公告）日：2016-02-17

  우수한 EP4 수용체 길항 작용을 갖고, EP4 수용체가 관련된 질환의 처치용 의약, 예를 들어 염증성 질환이나 여러 가지 동통을 수반하는 질환의 소염 및/또는 진통약, 또한 Th1 세포 및/또는 Th17 세포가 활성화되어, 조직 파괴가 발생하여 염증이 야기됨으로써 생기는 면역성 질환의 처치용 의약으로서 유용한 하기 일반식 (I) 로 나타내는 4-알키닐이미다졸 유도체 혹은 그 약리학적으로 허용되는 염을 제공한다. [화학식 1]

  具有优异的EP4受体拮抗作用，EP4受体相关的治疗疾病的药物，例如用于治疗炎症性疾病或伴有多种疼痛的疾病的抗炎和/或镇痛药物，同时也激活Th1细胞和/或Th17细胞，导致组织破坏引起炎症导致的免疫性疾病的治疗药物，提供4-烷基咪唑衍生物或其药理学上可接受的盐，如下所示的通用式(I)。【化学式1】
• AMIDE COMPOUNDS
  申请人：Nozawa Eisuke

  公开号：US20110028463A1

  公开（公告）日：2011-02-03

  [Problems] To provide a compound that is useful as an agent for treating chronic renal insufficiency or an agent for treating diabetic nephropathy. [Means for Solving Problems] The present inventors have conducted extensive studies on a compound having an EP4 receptor antagonistic action, and as a result, they have found that various amide derivatives having a carboxylic group or an equivalent thereof exhibit an excellent EP4 receptor antagonistic action, thereby completing the present invention. Since the compound of the present invention has an excellent EP4 receptor antagonistic action, it is useful as an agent for preventing and/or treating chronic renal insufficiency or diabetic nephropathy.

  【问题】提供一种可用作治疗慢性肾功能不全或糖尿病肾病的药物化合物。 【解决问题的方法】本发明者对具有EP4受体拮抗作用的化合物进行了广泛的研究，结果发现具有羧酸基或其等效物的各种酰胺衍生物表现出优异的EP4受体拮抗作用，从而完成了本发明。由于本发明的化合物具有优异的EP4受体拮抗作用，因此可用作预防和/或治疗慢性肾功能不全或糖尿病肾病的药物。
• AMIDE COMPOUND
  申请人：Astellas Pharma Inc.

  公开号：EP2172447A1

  公开（公告）日：2010-04-07

  [Problems] To provide a compound that is useful as an agent for treating chronic renal insufficiency or an agent for treating diabetic nephropathy. [Means for Solving Problems] The present inventors have conducted extensive studies on a compound having an EP4 receptor antagonistic action, and as a result, they have found that various amide derivatives having a carboxylic group or an equivalent thereof exhibit an excellent EP4 receptor antagonistic action, thereby completing the present invention. Since the compound of the present invention has an excellent EP4 receptor antagonistic action, it is useful as an agent for preventing and/or treating chronic renal insufficiency or diabetic nephropathy.

  [问题]提供一种可作为治疗慢性肾功能不全的药物或治疗糖尿病肾病的药物的化合物。 [解决问题的方法]本发明人对具有 EP4 受体拮抗作用的化合物进行了广泛的研究，结果发现具有羧基或其等价物的各种酰胺衍生物具有优异的 EP4 受体拮抗作用，从而完成了本发明。 由于本发明的化合物具有优异的 EP4 受体拮抗作用，因此可用作预防和/或治疗慢性肾功能不全或糖尿病肾病的药物。
• Amide compounds and their use as PGE2 antagonists.
  申请人：Astellas Pharma Inc.

  公开号：EP2460787A1

  公开（公告）日：2012-06-06

  [Problems] To provide a compound that is useful as an agent for treating chronic renal insufficiency or an agent for treating diabetic nephropathy. [Means for Solving Problems] The present inventors have conducted extensive studies on a compound having an EP4 receptor antagonistic action, and as a result, they have found that various amide derivatives having a carboxylic group or an equivalent thereof exhibit an excellent EP4 receptor antagonistic action, thereby completing the present invention. Since the compound of the present invention has an excellent EP4 receptor antagonistic action, it is useful as an agent for preventing and/or treating chronic renal insufficiency or diabetic nephropathy.

  [问题]提供一种可作为治疗慢性肾功能不全的药物或治疗糖尿病肾病的药物的化合物。 [解决问题的方法]本发明人对具有 EP4 受体拮抗作用的化合物进行了广泛的研究，结果发现具有羧基或其等价物的各种酰胺衍生物具有优异的 EP4 受体拮抗作用，从而完成了本发明。 由于本发明的化合物具有优异的 EP4 受体拮抗作用，因此可用作预防和/或治疗慢性肾功能不全或糖尿病肾病的药物。
• EP2172447
  申请人：——

  公开号：——

  公开（公告）日：——